Advanced search
Publication Cover
Infection and Drug Resistance Volume 17, 2024 - Issue
Submit an article Journal homepage
148
Views
0
CrossRef citations to date
0
Altmetric
CASE REPORT

Intrathecal Injection of Polymyxin B in a Child with Meningitis Caused by Carbapenem-Resistant Pseudomonas aeruginosa: A Case Report and Literature Review

Mei Wu1 Department of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu, People’s Republic of China;2 Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, Chengdu, People’s Republic of ChinaORCID Iconhttps://orcid.org/0009-0004-5941-4184View further author information
ORCID Icon,
Jingui Zhao1 Department of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu, People’s Republic of China;2 Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, Chengdu, People’s Republic of ChinaView further author information
,
Zhongqiang Liu1 Department of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu, People’s Republic of China;2 Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, Chengdu, People’s Republic of ChinaView further author information
&
Haiyang Zhang1 Department of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu, People’s Republic of China;2 Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, Chengdu, People’s Republic of ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-3511-9955View further author information
ORCID Icon
Pages 249-258 | Received 29 Oct 2023, Accepted 20 Jan 2024, Published online: 25 Jan 2024

References

  • Tabah A, Buetti N, Staiquly Q, et al. Epidemiology and outcomes of hospital-acquired bloodstream infections in intensive care unit patients: the EUROBACT-2 international cohort study. Intensive Care Med. 2023;49(2):178–190. doi:10.1007/s00134-022-06944-2
  • Xi J, Jia P, Zhu Y, et al. Antimicrobial susceptibility to polymyxin B and other comparators against Gram-negative bacteria isolated from bloodstream infections in China: results from CARVIS-NET program. Front Microbiol. 2022;13:1017488. doi:10.3389/fmicb.2022.1017488
  • Nation RL, Li J, Cars O, et al. Framework for optimisation of the clinical use of polymyxin and polymyxin B: the Prato polymyxin consensus. Lancet Infect Dis. 2015;15(2):225–234. doi:10.1016/S1473-3099(14)70850-3
  • Henter J-I, Horne A, Aricó M, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48(2):124–131. doi:10.1002/pbc.21039
  • Henter JI, Aricò M, Egeler RM, et al. HLH-94: a treatment protocol for hemophagocytic lymphohistiocytosis. HLH study Group of the Histiocyte Society. Med Pediatr Oncol. 1997;28(5):342–347. doi:10.1002/(sici)1096-911x(199705)28:5<342::aid-mpo3>3.0.co;2-h
  • Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing. In: CLSI Supplement M100-S32. Wayne, PA: Clinical and Laboratory Standards Institute; 2022.
  • Tsuji BT, Pogue JM, Zavascki AP, et al. International Consensus Guidelines for the Optimal Use of the Polymyxins: endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti‐infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP). Pharmacotherapy. 2019;39(1):10–39. doi:10.1002/phar.2209
  • Tunkel AR, Hasbun R, Bhimraj A, et al. 2017 Infectious Diseases Society of America’s Clinical Practice Guidelines for Healthcare-Associated Ventriculitis and Meningitis. Clin Infect Dis. 2017;64(6):e34–e65. doi:10.1093/cid/ciw861
  • Li Z, Velkov T. Polymyxins: mode of Action. Adv Exp Med Biol. 2019;1145:37–54. doi:10.1007/978-3-030-16373-0_4
  • Dai C, Xiao X, Li J, et al. Molecular Mechanisms of Neurotoxicity Induced by Polymyxins and Chemoprevention. ACS Chem Neurosci. 2019;10(1):120–131. doi:10.1021/acschemneuro.8b00300
  • Azad MAK, Nation RL, Velkov T, Li J. Mechanisms of Polymyxin-Induced Nephrotoxicity. Adv Exp Med Biol. 2019;1145:305–319. doi:10.1007/978-3-030-16373-0_18
  • Truong CB, Durham SH, Qian J. Comparisons of adverse event reporting for polymyxin versus polymyxin B using the US Food and Drug Administration Adverse Event Reporting System (FAERS). Expert Opin Drug Saf. 2021;20(5):603–609. doi:10.1080/14740338.2021.1890024
  • Thomas R, Velaphi S, Ellis S, et al. The use of polymyxins to treat carbapenem resistant infections in neonates and children. Expert Opin Pharmacother. 2019;20(4):415–422. doi:10.1080/14656566.2018.1559817
  • Tran TB, Velkov T, Nation RL, et al. Pharmacokinetics/pharmacodynamics of polymyxin and polymyxin B: are we there yet? Int J Antimicrob Agents. 2016;48(6):592–597. doi:10.1016/j.ijantimicag.2016.09.010
  • Velkov T, Dai C, Ciccotosto GD, Cappai R, Hoyer D, Li J. Polymyxins for CNS infections: pharmacology and neurotoxicity. Pharmacol Ther. 2018;181:85–90. doi:10.1016/j.pharmthera.2017.07.012
  • Piparsania S, Rajput N, Bhatambare G. Intraventricular polymyxin B for the treatment of neonatal meningo-ventriculitis caused by multi-resistant Acinetobacter baumannii--case report and review of literature. Turk J Pediatr. 2012;54(5):548–554.
  • Ye J, Tan L-H, Shen Z-P, et al. Polymyxin for the treatment of intracranial infections of extensively drug-resistant bacteria in children after neurosurgical operation. World J Pediatr. 2020;16(5):528–532. doi:10.1007/s12519-020-00350-8
  • Xing H, Cheng C, Zhang Y, et al. Successful Treatment With Intrathecal and Intravenous Polymyxin B-Based Combination Against MDR Acinetobacter baumannii Meningitis in Pediatric Patient: a Case Report. Front Pediatr. 2021;9:564991. doi:10.3389/fped.2021.564991
  • Fitzrol DN, Ang SY, Suhaimi A, Yeap TB. Rare occurrence of polymyxin B-induced hyperpigmentation in a child with ventriculitis. BMJ Case Rep. 2023;16:4. doi:10.1136/bcr-2022-253959
  • Bhandari RK, Pandey AK, Shafiq N, et al. polymyxin disposition in the cerebrospinal fluid when administered either intravenously alone or with intraventricular/intrathecally in neonates/pediatric patients with culture-proven meningitis. Pediatr Neonatol. 2022;63(2):190–191. doi:10.1016/j.pedneo.2021.07.012

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.